Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 5, 2015, Pages 547-553

  Vale, Thiago Cardoso ^a   Caramelli, Paulo ^b   Cardoso, Francisco ^b  

^a University Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BALANCE IMPAIRMENT; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FALLING; FEMALE; GAIT DISORDER; HUMAN; HYPERTENSION; LACUNAR STROKE; MALE; MIDDLE AGED; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PYRAMIDAL SIGN; UNIFIED PARKINSON DISEASE RATING SCALE; URINE INCONTINENCE; VASCULAR PARKINSONISM; WHITE MATTER LESION; BRAIN; PARKINSON DISEASE, SECONDARY; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; SYMPTOM ASSESSMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; SYMPTOM ASSESSMENT;

EID: 84927666971     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307867     Document Type: Article

References (50)

1. Vale T, Barbosa MT, Caramelli P, et al. Vascular parkinsonism and cognitive impairment: literature review, Brazilian studies and case vignettes. Dement Neuropsychol 2012;6:137-44.
2. Gupta D, Kuruvilla A. Vascular parkinsonism: what makes it different? Postgrad Med J 2011;87:829-36.
3. Fitzgerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989;4:249-60.
4. Critchley M. Arteriosclerotic parkinsonism. Brain 1929;52:23-83
5. Eadie MJ, Sutherland JM. Arteriosclerosis in parkinsonism. JNNP 1964;27:237-40.
6. Critchley M. Arteriosclerotic pseudo-parkinsonism. In: Rose FC, Capildeo R, eds. Research progress in Parkinson 's disease. London: Pitman Medical, 1981:40-2.
7. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
8. Zijlmans JC, Daniel SE, Hughes AJ, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004;19:630-40.
9. Kalra S, Grosset DG, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010;25:149-56.
10. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson' s disease: a clinico-pathological study of 100 cases. JNNP 1992;55:181-4.
11. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson' s disease. Neurology 2001;57:1497-9.
12. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
13. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-8.
14. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
15. Moroney JT, Bagiella E, Desmond DW, et al . Meta-analysis of the Hachinski Ischemic Score in pathologically veri fied dementias. Neurology 1997;49:1096-105.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
17. Brucki SM, Nitrini R, Caramelli P, et al. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 2003;61:777-81.
18. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-6.
19. Beato R, Amaral-Carvalho V, Guimaraes HC, et al. Frontal assessment battery in a Brazilian sample of healthy controls: normative data. Arq Neuropsiquiatr 2012;70:278-80.
20. Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc 1992;40:1221-6.
21. Matioli MNPS, Caramelli P, Marques BD, et al. EXIT25- Executive Interview applied to a cognitively healthy elderly population with heterogeneous educational backgroud. Dement Neuropsychol 2008;2:305-9.
22. Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
23. Pfeffer RI, Kurosaki TT, Harrah CH Jr, et al. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-9.
24. Giladi N, Tal J, Azulay T, et al. Validation of the freezing of gait questionnaire in patients with Parkinson 's disease. Mov Disord 2009;24:655-61.
25. Baggio JA, Curtarelli MB, Rodrigues GR, et al. Validity of the Brazilian version of the freezing of gait questionnaire. Arq Neuropsiquiatr 2012;70:599-603.
26. Fahn SER; UPDRS Program Members. Unified Parkinson's disease rating scale. Vol 2. Florham Park, NJ: Macmillan Healthcare Information, 1987.
27. Ramaker C, Marinus J, Stiggelbout AM, et al. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord 2002;17:867-76.
28. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR 1987;149:351-6.
29. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
30. th edn. Philadelphia: Lippincott Williams and Wilkins, 2006:692-701.
31. Clarke CE, Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson' s disease. JNNP 2000;69:590-4.
32. Yamanouchi H, Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 1997;28:965-9.
33. Okuda B, Kawabata K, Tachibana H, et al. Primitive reflexes distinguish vascular parkinsonism from Parkinson 's disease. Clin Neurol Neurosurg 2008;110:562-5.
34. Glass PG, Lees AJ, Bacellar A, et al. The clinical features of pathologically confirmed vascular parkinsonism. JNNP 2012;83:1027-9.
35. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001;104:63-7.
36. Rampello L, Alvano A, Battaglia G, et al. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism. J Neurol 2005;252:1045-9.
37. Zijlmans J, Evans A, Fontes F, et al. [123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson 's disease. Mov Disord 2007;22:1278-85.
38. Kandiah N, Maka E, Ng A, et al. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat Disord 2013;19:680-3.
39. Santangelo G, Vitale C, Trojano L, et al. Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov Disord 2010;25:50-6.
40. Bohnen NI, Albin RL. White matter lesions in Parkinson disease. Nat Rev Neurol 2011;7:229-36.
41. Thanvi B, Lo N, Robinson T. Vascular parkinsonism-an important cause of parkinsonism in older people. Age Ageing 2005;34:114-19.
42. Buchman AS, Leurgans SE, Nag S, et al. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke 2011;42:3183-9.
43. Herman T, Rosenberg-Katz K, Jacob Y, et al. White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes? PLoS ONE 2013;8:e55193.
44. Horvath J, Burkhard PR, Bouras C, et al. Etiologies of parkinsonism in a century-long autopsy-based cohort. Brain Pathol 2013;23:28-33.
45. Bower JH, Dickson DW, Taylor L, et al. Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov Disord 2002;17:910-16.
46. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-25.
47. Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-70.
48. Kurlan R, Richard IH, Papka M, et al. Movement disorders in Alzheimer's disease: more rigidity of defi nitions is needed. Mov Disord 2000;15:24-9.
49. Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol 2013;12:597-608.
50. Katzensachlager R, Zijlmans J, Evans A, et al. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. JNNP 2004;75:1749-52.